BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 8633548)

  • 1. Mesalamine-induced lung toxicity.
    Bitton A; Peppercorn MA; Hanrahan JP; Upton MP
    Am J Gastroenterol; 1996 May; 91(5):1039-40. PubMed ID: 8633548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesalamine lung toxicity.
    Jain N; Petruff C; Bandyopadhyay T
    Conn Med; 2010 May; 74(5):265-7. PubMed ID: 20509416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesalamine-induced lung injury in a patient with ulcerative colitis and a confounding autoimmune background: a case report.
    Actis GC; Ottobrelli A; Baldi S; Scappaticci E; Modena V; Fusaro E; Mengozzi G; Rizzetto M
    Mt Sinai J Med; 2005 Mar; 72(2):136-40. PubMed ID: 15770345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis.
    Pruitt R; Hanson J; Safdi M; Wruble L; Hardi R; Johanson J; Koval G; Riff D; Winston B; Cross A; Doty P; Johnson LK
    Am J Gastroenterol; 2002 Dec; 97(12):3078-86. PubMed ID: 12492193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ulcerative colitis and pericarditis. The role of mesalazine hypersensitivity].
    Loizeau E
    Rev Med Suisse Romande; 1995 Nov; 115(11):935-8. PubMed ID: 8525252
    [No Abstract]   [Full Text] [Related]  

  • 6. Folliculitis and mesalamine.
    Lizasoain J; Rubio FA; Erdozain JC; Olveira A; Conde P
    Am J Gastroenterol; 1996 Apr; 91(4):819-20. PubMed ID: 8677969
    [No Abstract]   [Full Text] [Related]  

  • 7. [Characterization of proteinuria in patients with ulcerative colitis and therapy with aminosalicylates].
    Buschhausen L; Kruis W; Aymaz S; Weber M; Krakamp B
    Med Klin (Munich); 2006 Oct; 101(10):791-5. PubMed ID: 17039321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [False melanuria in a female patient treated with 5-ASA for ulcerative colitis].
    Cuende JI; Gómez MT; García M; Pérez IJ
    Med Clin (Barc); 1995 May; 104(20):798. PubMed ID: 7783478
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mesalamine-induced hypersensitivity pneumonitis].
    Zamir D; Weizman J; Zamir C; Fireman Z; Weiner P
    Harefuah; 1999 Jul; 137(1-2):28-30, 87, 86. PubMed ID: 10959271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autoimmune hemolytic anemia and ulcerative colitis].
    Rebocho L; Lucas M; Victorino RM
    Acta Med Port; 1995 Dec; 8(12):701-3. PubMed ID: 8669321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleuropericarditis in a patient with ulcerative colitis in longstanding 5-aminosalicylic acid therapy.
    Iaquinto G; Sorrentini I; Petillo FE; Berardesca G
    Ital J Gastroenterol; 1994 Apr; 26(3):145-7. PubMed ID: 8061342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Eosinophilic pneumonia caused by mesalazine. Report of one case].
    Pérez C; Errázuriz I; Brockmann P; González S; Cofré C
    Rev Med Chil; 2003 Jan; 131(1):81-4. PubMed ID: 12643224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesalazine-induced eosinophilic variant of Wegener's granulomatosis in an ulcerative colitis patient.
    Fayaz M; Sultan A; Nawaz M; Sultan N
    J Ayub Med Coll Abbottabad; 2009; 21(4):171-3. PubMed ID: 21067054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis.
    Levine DS; Riff DS; Pruitt R; Wruble L; Koval G; Sales D; Bell JK; Johnson LK
    Am J Gastroenterol; 2002 Jun; 97(6):1398-407. PubMed ID: 12094857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological bases of therapy with 5-ASA].
    Beltrán B; Martínez-Cuesta MA; Calatayud S; Hinojosa J; Esplugues JV
    Gastroenterol Hepatol; 1997; 20(6):322-34. PubMed ID: 9296850
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mesalazine].
    Engelhardt K; Mohr K
    Dtsch Med Wochenschr; 1995 May; 120(21):769-70. PubMed ID: 7781502
    [No Abstract]   [Full Text] [Related]  

  • 17. [Peripheral eosinophilia in ulcerative colitis: apropos of a case].
    Galofre N; Fuste L; Oriol A; Grau J
    Gastroenterol Hepatol; 1997 Mar; 20(3):163. PubMed ID: 9162539
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pentasa (mesalazine) and pregnancy].
    Jonville-Bera AP; Soyez C; Fignon A; Moraine C; Berger C; Autret E
    Therapie; 1994; 49(5):443-5. PubMed ID: 7855761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung disease associated with orally administered mesalamine for ulcerative colitis.
    Reinoso MA; Schroeder KW; Pisani RJ
    Chest; 1992 May; 101(5):1469-71. PubMed ID: 1582327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis.
    Marshall JK; Irvine EJ
    Am J Gastroenterol; 2000 Jul; 95(7):1628-36. PubMed ID: 10925961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.